CTLT | Catalent

106.68 -3.16 (-2.88%)

CTLT Price Profile

Open

$107.73

CLOSE

$106.68

DAY RANGE

106.01 - 108.74

52 WEEK RANGE

86.34 - 142.64

MARKET CAP

17.31B

Trading volume

321.6K

Prev. Close

109.84

50 Day MA

121.66

Shares Outstanding

171.19M

Public Float

170.44M

Average Volume

1.11M

Beta

1.32

PEG Ratio

1.68

Shares Shorted

1.41M

% OF SHARES SHORTED

1.06%

Short Ratio

1.33

1 Year Performance

-8.40%

Diluted EPS (TTM)

3.18

Q Revenue Growth

0.21

Ebitda

1.02B

Gross Profit (TTM)

1.35B

Total Cash (MRQ)

2.02B

Total Debt (MRQ)

4.32B

  • MRQ = Most Recent Quarter.
  • TTM = Trailing Twelve Months.

Catalent (CTLT) company profile

Catalent Inc. (NYSE: CTLT) is a medical company that provides delivery technologies and development and manufacturing solutions for drugs, protein, cell, gene therapy biologics and consumer health products. It operates through the segments of Softgel and Oral Technologies, Biologics, Oral and Specialty Delivery, and Clinical Supply Services. Catalent also provides packaging services, labelling, storage, distribution, and inventory management for clinical drug trials.

Latest CTLT News

AD